Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 23 trials
Active filters
Clinical trials found
Published and searchable clinical trials
NCT05278208
- Conditions
- Anaplastic Ependymoma, Brain Diseases, Brain Neoplasms, +32 more
- Locations
-
- Children's Hospital Colorado Aurora, Colorado, United States
- Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
- Nationwide Children's Hospital Columbus, Ohio, United States
- Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
NCT03896568
- Conditions
- Astrocytoma, Glioblastoma, Glioma, +13 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT06964737
- Conditions
- Glioma, Neoplasms, Neoplasms by Histologic Type, +11 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT07481721
- Conditions
- Glioma, Neoplasms, Neoplasms by Histologic Type, +6 more
- Locations
-
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, Beijing Municipality, China
- Conditions
- Advanced Malignant Solid Neoplasm, Ann Arbor Stage III Hodgkin Lymphoma, Ann Arbor Stage III Non-Hodgkin Lymphoma, +91 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Banner Children's at Desert Mesa, Arizona, United States
- Phoenix Childrens Hospital Phoenix, Arizona, United States
- Conditions
- Advanced Malignant Solid Neoplasm, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Ependymoma, +81 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Banner Children's at Desert Mesa, Arizona, United States
- Phoenix Childrens Hospital Phoenix, Arizona, United States
NCT04388475
- Conditions
- Brain Glioblastoma, Glioma, Neoplasms, +7 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
- Providence Saint John's Health Center - John Wayne Cancer Institute Santa Monica, California, United States
- Swedish Medical Center Englewood, Colorado, United States
NCT01904123
- Conditions
- Astrocytoma, Brain Diseases, Brain Neoplasms, +25 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Savolitinib in Treating Patients With Recurrent or Refractory Primary CNS Tumors
NCT03598244
- Conditions
- Brain Diseases, Brain Neoplasms, Brain Stem Neoplasms, +25 more
- Locations
-
- Children's Hospital Los Angeles Los Angeles, California, United States
- Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
- Children's Hospital Colorado Aurora, Colorado, United States
- Children's National Medical Center Washington D.C., District of Columbia, United States
Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma
NCT02208362
- Conditions
- Astrocytoma, Glioblastoma, Glioma, +15 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial
NCT04284774
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine Gland Neoplasms, Endocrine System Diseases, +102 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Banner Children's at Desert Mesa, Arizona, United States
- Phoenix Childrens Hospital Phoenix, Arizona, United States
Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)
NCT03213652
- Conditions
- Advanced Malignant Solid Neoplasm, Central Nervous System Neoplasms, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +82 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Banner Children's at Desert Mesa, Arizona, United States
- Banner University Medical Center - Tucson Tucson, Arizona, United States
Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial)
NCT04195555
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Ependymoma, Female Urogenital Diseases, +80 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Banner Children's at Desert Mesa, Arizona, United States
- Phoenix Childrens Hospital Phoenix, Arizona, United States
Chimeric Antigen Receptor (CAR) T Cells With a Chlorotoxin Tumor-Targeting Domain for the Treatment of MMP2+ Recurrent or Progressive Glioblastoma
NCT04214392
- Conditions
- Astrocytoma, Glioblastoma, Glioma, +11 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)
NCT03213704
- Conditions
- Advanced Malignant Solid Neoplasm, Central Nervous System Neoplasms, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +83 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Banner Children's at Desert Mesa, Arizona, United States
- Banner University Medical Center - Tucson Tucson, Arizona, United States
Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial
NCT04320888
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Ependymoma, Female Urogenital Diseases, +85 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Banner Children's at Desert Mesa, Arizona, United States
- Phoenix Childrens Hospital Phoenix, Arizona, United States
Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)
NCT03210714
- Conditions
- Advanced Malignant Solid Neoplasm, Central Nervous System Neoplasms, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +74 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Banner Children's at Desert Mesa, Arizona, United States
- Banner University Medical Center - Tucson Tucson, Arizona, United States
Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young Adults
NCT04323046
- Conditions
- Astrocytoma, Glioblastoma, Glioma, +12 more
- Locations
-
- University of Alabama at Birmingham, Children's of Alabama Birmingham, Alabama, United States
- Children's Hospital of Los Angeles Los Angeles, California, United States
- Rady Children's Hospital San Diego, California, United States
- University of California, San Francisco San Francisco, California, United States
Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas
NCT02192359
- Conditions
- Astrocytoma, Glioblastoma, Glioma, +16 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Comprehensive Analysis of Chemotherapy and Targeted Therapy Outcomes in Recurrent Malignant Gliomas
NCT07448480
- Conditions
- Anaplastic Astrocytoma, Astrocytoma, Glioblastoma, +10 more
- Locations
-
- Blokhin's Russian Cancer Research Center Moscow, Russia